Despites all the pandemic complexities, Fight Against Cancer, a large-scale federal project, is being implemented in Russia. What challenges is it intended to tackle? How will changes affect healthcare facilities, doctors, and the health of patieцnts? These are the issues which the 15th Scientific Council Meeting entitled “Oncology Service of Russia. Approaching the Future” will address. The Pharmasyntez Group of Companies is the general partner of the Council.

On November 24, in live broadcast on Doctor TV channel, experts, doctors, patients and pharmaceutical industry representatives will discuss topical issues of cancer treatment.

Mikhail Shurygin, Chief R&D Officer of Pharmasyntez, will be a speaker at the plenary session.

The 3rd session of the Scientific Council will be devoted to peculiarities of anticancer drug production. Oleg Astafurov, the Vice President of Government Relations, Pharmasyntez, will report on possibilities of interaction of regulators, medical community, and pharmaceutical companies in making a request for the production of drugs and will share real-life experience and tell about opportunities and obstacles in building a full cycle production of anticancer drugs in Russia.